REGENXBIO, Inc. (RGNX)
8.06
-2.66
(-24.81%)
USD |
NASDAQ |
Aug 24, 16:00
8.08
+0.02
(+0.25%)
After-Hours: 20:00
REGENXBIO Max Drawdown (5Y) : 89.37% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 89.37% |
| June 30, 2026 | 89.37% |
| May 31, 2026 | 89.37% |
| April 30, 2026 | 89.37% |
| March 31, 2026 | 89.37% |
| February 28, 2026 | 89.37% |
| January 31, 2026 | 89.37% |
| December 31, 2025 | 89.37% |
| November 30, 2025 | 89.37% |
| October 31, 2025 | 89.37% |
| September 30, 2025 | 89.37% |
| August 31, 2025 | 89.37% |
| July 31, 2025 | 89.37% |
| June 30, 2025 | 89.37% |
| May 31, 2025 | 89.37% |
| April 30, 2025 | 89.37% |
| March 31, 2025 | 88.15% |
| February 28, 2025 | 87.18% |
| January 31, 2025 | 87.18% |
| December 31, 2024 | 86.66% |
| November 30, 2024 | 84.15% |
| October 31, 2024 | 84.15% |
| September 30, 2024 | 82.53% |
| August 31, 2024 | 82.53% |
| July 31, 2024 | 82.53% |
| Date | Value |
|---|---|
| June 30, 2024 | 82.53% |
| May 31, 2024 | 82.53% |
| April 30, 2024 | 82.53% |
| March 31, 2024 | 82.53% |
| February 29, 2024 | 82.53% |
| January 31, 2024 | 82.53% |
| December 31, 2023 | 82.53% |
| November 30, 2023 | 82.53% |
| October 31, 2023 | 82.53% |
| September 30, 2023 | 79.03% |
| August 31, 2023 | 79.03% |
| July 31, 2023 | 79.03% |
| June 30, 2023 | 79.03% |
| May 31, 2023 | 79.03% |
| April 30, 2023 | 78.99% |
| March 31, 2023 | 77.99% |
| February 28, 2023 | 76.45% |
| January 31, 2023 | 76.45% |
| December 31, 2022 | 76.45% |
| November 30, 2022 | 76.45% |
| October 31, 2022 | 76.45% |
| September 30, 2022 | 76.45% |
| August 31, 2022 | 76.45% |
| July 31, 2022 | 76.45% |
| June 30, 2022 | 76.45% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| AbbVie, Inc. | 21.89% |
| Capricor Therapeutics, Inc. | 91.80% |
| Biogen, Inc. | 72.66% |
| Ardelyx, Inc. | 95.65% |
| Ocugen, Inc. | 99.77% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -33.70 |
| Beta (5Y) | 0.9382 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 75.68% |
| Historical Sharpe Ratio (5Y) | -0.3312 |
| Historical Sortino (5Y) | -0.7436 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 27.22% |